DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structure-guided design of pure orthosteric inhibitors of αIIbβ3 that prevent thrombosis but preserve hemostasis

Journal Article · · Nature Communications
 [1];  [1];  [1];  [2];  [2]; ORCiD logo [3];  [4];  [1];  [2]; ORCiD logo [1]
  1. Massachusetts General Hospital, Boston, MA (United States); Harvard Medical School, Boston, MA (United States)
  2. The Children's Hospital of Philadelphia, PA (United States)
  3. National Taiwan Univ., Taipei (Taiwan). Lab. Animal Center
  4. National Taiwan Univ., Taipei (Taiwan)

A prevailing dogma is that inhibition of vascular thrombosis by antagonizing platelet integrin αIIbβ3 cannot be achieved without compromising hemostasis, thus causing serious bleeding and increased morbidity and mortality. It is speculated that these adverse outcomes result from drug-induced activating conformational changes in αIIbβ3 but direct proof is lacking. Here, we report the structure-guided design of peptide Hr10 and a modified form of the partial agonist drug tirofiban that act as “pure” antagonists of αIIbβ3, i.e., they no longer induce the conformational changes in αIIbβ3. Both agents inhibit human platelet aggregation but preserve clot retraction. Hr10 and modified tirofiban are as effective as partial agonist drugs in inhibiting vascular thrombosis in humanized mice, but neither causes serious bleeding, establishing a causal link between partial agonism and impaired hemostasis. Pure orthosteric inhibitors of αIIbβ3 may thus provide safer alternatives for human therapy, and valuable tools to probe structure–activity relationships in integrins.

Research Organization:
Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
Sponsoring Organization:
National Institutes of Health (NIH); USDOE Office of Science (SC)
OSTI ID:
1838536
Journal Information:
Nature Communications, Journal Name: Nature Communications Journal Issue: 1 Vol. 11; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
ENGLISH

References (108)

Cystine-knot peptides engineered with specificities for αIIbβ3 or αIIbβ3 and αvβ3 integrins are potent inhibitors of platelet aggregation journal May 2010
Heart Failure Is Not Going Anywhere: Good News, Bad News journal April 2017
Structure and mechanics of integrin-based cell adhesion journal October 2007
The Spectrophotometric Determination of Certain Blood Pigments journal October 1932
Engineered Fibronectin Type III Domain with a RGDWXE Sequence Binds with Enhanced Affinity and Specificity to Human αvβ3 Integrin journal March 2003
Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists journal March 1998
Integrin Priming Dynamics: Mechanisms of Integrin Antagonist-Promoted αIIbβ3:PAC-1 Molecular Recognition journal August 2009
A directional switch of integrin signalling and a new anti-thrombotic strategy journal October 2013
Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα journal May 2017
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism journal March 2002
Novel antiplatelet agents in acute coronary syndrome journal October 2014
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin journal March 2014
A Novel Regulatory Epitope Defined by a Murine Monoclonal Antibody to the Platelet GPIIb-IIIa Complex (αIIbβ3 Integrin) journal January 1996
Vorapaxar in the Secondary Prevention of Atherothrombotic Events journal April 2012
Small-molecule inhibitors of integrin α 2 β 1 that prevent pathological thrombus formation via an allosteric mechanism journal January 2009
Topography of Ligand-induced Binding Sites, Including a Novel Cation-sensitive Epitope (AP5) at the Amino Terminus, of the Human Integrin Subunit journal May 1995
Fibrin Clot Retraction by Human Platelets Correlates with αIIbβ3Integrin-dependent Protein Tyrosine Dephosphorylation journal March 2001
The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen journal April 2016
Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin α IIb β 3 journal August 2008
Advances in understanding percutaneous coronary intervention pharmacology journal September 2014
Features and development of Coot journal March 2010
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo journal October 2006
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 journal September 2001
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand journal March 2002
Structure-Guided Design of a High-Affinity Platelet Integrin  IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS journal March 2012
The Roles of Platelet GPIIb/IIIa and αvβ3 Integrins during HeLa Cells Adhesion, Migration, and Invasion to Monolayer Endothelium under Static and Dynamic Shear Flow journal January 2009
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction journal October 2014
Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice journal November 2011
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents journal January 2011
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation journal December 2015
Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia journal February 2017
Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors journal February 2003
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend journal October 2008
Talin-dependent integrin activation is required for fibrin clot retraction by platelets journal February 2011
Full reconstitution of human platelets in humanized mice after macrophage depletion journal August 2012
Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase–dependent calcium stores journal August 2016
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42 journal May 1993
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics: Insights from Computational Analyses and Implications for Molecular Design journal January 2017
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Hemodialysis access thrombosis journal December 2017
Cystine-knot peptides engineered with specificities for αIIbβ3 or αIIbβ3 and αvβ3 integrins are potent inhibitors of platelet aggregation journal May 2010
Breast adenocarcinoma cell adhesion to the vascular subendothelium in whole blood and under flow conditions: Effects of α v β 3 and α IIb β 3 antagonists journal December 2004
Effects of 2 different antiplatelet regimens with abciximab or tirofiban on platelet function in patients undergoing coronary stenting journal November 2003
Variable responses to inhibition of fibrinogen binding induced by tirofiban and eptifibatide in blood from healthy subjects journal July 1999
Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization11The names and institutions participating in these trials are provided in the appendices of references 1 to 3. journal July 2002
The Spectrophotometric Determination of Certain Blood Pigments journal October 1932
Selective recognition of adhesive sites in surface-bound fibrinogen by glycoprotein IIb-IIIa on nonactivated platelets journal June 1991
Engineered Fibronectin Type III Domain with a RGDWXE Sequence Binds with Enhanced Affinity and Specificity to Human αvβ3 Integrin journal March 2003
Inhibition of Platelet-Mediated Clot Retraction by Integrin Antagonists journal March 1998
[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction journal February 2017
Structure and mechanics of integrin-based cell adhesion journal October 2007
Discovery and antiplatelet activity of a selective PI3Kβ inhibitor (MIPS-9922) journal October 2016
Integrin Priming Dynamics: Mechanisms of Integrin Antagonist-Promoted αIIbβ3:PAC-1 Molecular Recognition journal August 2009
Comparative Pharmacology of GP IIb/IIIa Antagonists journal April 2003
A directional switch of integrin signalling and a new anti-thrombotic strategy journal October 2013
Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα journal May 2017
CD40L stabilizes arterial thrombi by a β3 integrin–dependent mechanism journal March 2002
Novel antiplatelet agents in acute coronary syndrome journal October 2014
Integrin-based therapeutics: biological basis, clinical use and new drugs journal January 2016
Structural basis for pure antagonism of integrin αVβ3 by a high-affinity form of fibronectin journal March 2014
A Novel Regulatory Epitope Defined by a Murine Monoclonal Antibody to the Platelet GPIIb-IIIa Complex (αIIbβ3 Integrin) journal January 1996
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes journal September 2009
Vorapaxar in the Secondary Prevention of Atherothrombotic Events journal April 2012
Small-molecule inhibitors of integrin α 2 β 1 that prevent pathological thrombus formation via an allosteric mechanism journal January 2009
Topography of Ligand-induced Binding Sites, Including a Novel Cation-sensitive Epitope (AP5) at the Amino Terminus, of the Human Integrin Subunit journal May 1995
Tyrosine Phosphorylation of the β3 Cytoplasmic Domain Mediates Integrin-Cytoskeletal Interactions journal May 1998
Fibrin Clot Retraction by Human Platelets Correlates with αIIbβ3Integrin-dependent Protein Tyrosine Dephosphorylation journal March 2001
The Interaction of Integrin αIIbβ3 with Fibrin Occurs through Multiple Binding Sites in the αIIb β-Propeller Domain journal January 2014
The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen journal April 2016
Structural basis for distinctive recognition of fibrinogen γC peptide by the platelet integrin α IIb β 3 journal August 2008
Clot Retraction journal October 1952
Three-year duration of benefit from abciximab in patient receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study journal October 2005
Reassignment of a rare sense codon to a non-canonical amino acid in Escherichia coli journal August 2015
Renal allograft thrombosis journal January 2009
Correlates of poor outcome among patients with bleeding after coronary interventions journal January 2014
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Features and development of Coot journal March 2010
Fibrinogen and von Willebrand factor-independent platelet aggregation in vitro and in vivo journal October 2006
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 journal September 2001
Crystal Structure of the Extracellular Segment of Integrin alpha Vbeta 3 in Complex with an Arg-Gly-Asp Ligand journal March 2002
Structure-Guided Design of a High-Affinity Platelet Integrin  IIb 3 Receptor Antagonist That Disrupts Mg2+ Binding to the MIDAS journal March 2012
Comparative In Vitro Efficacy of Different Platelet Glycoprotein IIb/IIIa Antagonists on Platelet-Mediated Clot Strength Induced by Tissue Factor With Use of Thromboelastography: Differentiation Among Glycoprotein IIb/IIIa Antagonists journal April 2000
Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and α v β 3 Integrins journal September 1998
RUC-4: A Novel αIIbβ3 Antagonist for Prehospital Therapy of Myocardial Infarction journal October 2014
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association journal March 2017
Binding of CD40L to Mac-1's I-Domain Involves the EQLKKSKTL Motif and Mediates Leukocyte Recruitment and Atherosclerosis—But Does Not Affect Immunity and Thrombosis in Mice journal November 2011
Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding journal October 2017
Humanized Mouse Model of Thrombosis Is Predictive of the Clinical Efficacy of Antiplatelet Agents journal January 2011
Novel Antiplatelet Drug Revacept (Dimeric Glycoprotein VI-Fc) Specifically and Efficiently Inhibited Collagen-Induced Platelet Aggregation Without Affecting General Hemostasis in Humans journal May 2011
A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation journal December 2015
Endothelial antigen assembly leads to thrombotic complications in heparin-induced thrombocytopenia journal February 2017
Megakaryocyte-restricted MYH9 inactivation dramatically affects hemostasis while preserving platelet aggregation and secretion journal November 2007
The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend journal October 2008
Talin-dependent integrin activation is required for fibrin clot retraction by platelets journal February 2011
Full reconstitution of human platelets in humanized mice after macrophage depletion journal August 2012
Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? journal April 2013
Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase–dependent calcium stores journal August 2016
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa journal September 2002
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42 journal May 1993
Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied GPIIb/IIIa journal September 2002
Spreading of platelets on fibrin is mediated by the amino terminus of the beta chain including peptide beta 15-42 journal May 1993
Clot Retraction: Lost in Interpretation? journal January 2019
High Affinity vs. Native Fibronectin in the Modulation of αvβ3 Integrin Conformational Dynamics: Insights from Computational Analyses and Implications for Molecular Design journal January 2017
PHENIX: a comprehensive Python-based system for macromolecular structure solution. text January 2010
Hemodialysis access thrombosis journal December 2017
Function and Antagonism of β Integrins in the Development of Cancer Therapy journal June 2009
Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target? journal September 2017